The ALX/FPR2 receptor and 15-LOX (ALOX15) are expressed in the hippocampus of patients with Alzheimer’s disease suggesting that resolution mechanisms might be active in human CNS diseases with a pathogenic neuroinflammatory component. The gene discussed is ALOX15; the disease is early-onset autosomal dominant Alzheimer disease.